Develops thrombectomy devices for ischemic stroke and blood clots.
Jun 2026Revenue $1.50B/yrExpenses $1.32B/yr
No trend
Figures by year
Is Penumbra profitable?
Yes. In the 12 months to Jun 2026, revenue was $1.50B and expenses $1.32B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.40B | $1.21B | $189M |
| Dec 2024 | $1.19B | $1.19B | $9.28M |
| Dec 2023 | $1.06B | $985M | $73.6M |
| Dec 2022 | $847M | $841M | $6.08M |
| Dec 2021 | $748M | $755M | −$7.50M |
| Dec 2020 | $560M | $599M | −$38.9M |
| Dec 2019 | $547M | $500M | $47.5M |
| Dec 2018 | $445M | $446M | −$852K |
| Dec 2017 | $334M | $333M | $1.17M |
| Dec 2016 | $263M | $265M | −$1.35M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.